Literature DB >> 19594618

Analysis of telomere length in mantle cell lymphoma.

Alejandra S H Cottliar1, Julieta Panero, Estela Pedrazzini, Maria Fernanda Noriega, Marina Narbaitz, Andrea Rodríguez, Irma Slavutsky.   

Abstract

Mantle cell lymphoma (MCL) is a well defined lymphoid neoplasm genetically characterized by the t(11;14)(q13;q32). Telomeres play an essential role in preserving chromosomal integrity and genomic stability; their shortening can lead to telomere dysfunction and chromosomal instability, a critical factor in cancer development. In this study, telomere length (TL) measured by terminal restriction fragments (TRF) assay in DNA samples of tumor cells from 20 patients with MCL was evaluated. Results were correlated with clinical, morphologic and cytogenetic characteristics. In all cases, the presence of the CCND1/IGH@ rearrangement was confirmed by fluorescence in situ hybridization and/or PCR analysis. TL in total MCL patients revealed a mean TRF value (4.51 +/- 0.79 kb) significantly shorter than those observed in controls (7.49 +/- 1.94 kb) (P < 0.001); 30% of patients had TL shorter than 4.0 kb. TRF length was not associated with patients age (P = 0.07; r = 0.17) nor with sex (females: 4.33 +/- 0.51 kb and males: 4.57 +/- 0.85 kb; P = 0.63). No significant differences were found between patients studied at diagnosis (13) (4.44 +/- 0.81 kb) respect to those analyzed at relapse (7) (4.63 +/- 0.82 kb) (P = 0.53). In addition, we compared patients with (4.84 +/- 1.09 kb) and without (4.40 +/- 0.68 kb) complex karyotypes (P = 0.45) and cases with typical morphology (4.48 +/- 0.79 kb) vs. blastoid variant (4.63 +/- 1.04 kb) (P = 0.83), and no significant differences between them were found. Although the number of cases of our series is not large, our results showed that TL reduction in MCL is independent of the clinical characteristics, morphology and karyotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594618     DOI: 10.1111/j.1600-0609.2009.01313.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.

Authors:  Patricia Dos Santos; Julieta Panero; Virginia Palau Nagore; Carmen Stanganelli; Raimundo F Bezares; Irma Slavutsky
Journal:  Tumour Biol       Date:  2015-05-26

2.  A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma.

Authors:  Qing Lan; Richard Cawthon; Min Shen; Stephanie J Weinstein; Jarmo Virtamo; Unhee Lim; H Dean Hosgood; Demetrius Albanes; Nathaniel Rothman
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

3.  Expression profile of telomere-associated genes in multiple myeloma.

Authors:  Rafael Díaz de la Guardia; Purificación Catalina; Julieta Panero; Carolina Elosua; Andrés Pulgarin; María Belén López; Verónica Ayllón; Gertrudis Ligero; Irma Slavutsky; Paola E Leone
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

4.  Telomere Length, TERT, and miRNA Expression.

Authors:  Martha L Slattery; Jennifer S Herrick; Andrew J Pellatt; Roger K Wolff; Lila E Mullany
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.